Search

4 result(s) for 'author#Aron Charles Eklund' within BMC

1. Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets

   The European Union multi-disciplinary Personalised RNA interference to Enhance the Delivery of Individualised Cytotoxic and Targeted therapeutics (PREDICT) consortium has recently initiated a framework to acce...

   Authors: Charles Swanton, James M Larkin, Marco Gerlinger, Aron C Eklund, Michael Howell, Gordon Stamp, Julian Downward, Martin Gore, P Andrew Futreal, Bernard Escudier, Fabrice Andre, Laurence Albiges, Benoit Beuselinck, Stephane Oudard, Jens Hoffmann, Balázs Gyorffy…

   Citation: Genome Medicine 2010 2:53

   Content type: Correspondence Published on: 11 August 2010

   • View Full Text
   • View PDF

2. A united statement of the global chiropractic research community against the pseudoscientific claim that chiropractic care boosts immunity

   In the midst of the coronavirus pandemic, the International Chiropractors Association (ICA) posted reports claiming that chiropractic care can impact the immune system. These claims clash with recommendations ...

   Authors: Pierre Côté, André Bussières, J. David Cassidy, Jan Hartvigsen, Greg N. Kawchuk, Charlotte Leboeuf-Yde, Silvano Mior and Michael Schneider

   Citation: Chiropractic & Manual Therapies 2020 28:21

   Content type: Commentary Published on: 4 May 2020

   • View Full Text
   • View PDF

3. A robust prognostic gene expression signature for early stage lung adenocarcinoma

   Stage I lung adenocarcinoma is usually not treated with adjuvant chemotherapy; however, around half of these patients do not survive 5 years. Therefore, a reliable prognostic biomarker for early stage patients...

   Authors: Marcin Krzystanek, Judit Moldvay, David Szüts, Zoltan Szallasi and Aron Charles Eklund

   Citation: Biomarker Research 2016 4:4

   Content type: Research Published on: 19 February 2016

   • View Full Text
   • View PDF

4. TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen

   A substantial proportion of cancer cases present with a metastatic tumor and require further testing to determine the primary site; many of these are never fully diagnosed and remain cancer of unknown primary ...

   Authors: Andrea Marion Marquard, Nicolai Juul Birkbak, Cecilia Engel Thomas, Francesco Favero, Marcin Krzystanek, Celine Lefebvre, Charles Ferté, Mariam Jamal-Hanjani, Gareth A. Wilson, Seema Shafi, Charles Swanton, Fabrice André, Zoltan Szallasi and Aron Charles Eklund

   Citation: BMC Medical Genomics 2015 8:58

   Content type: Technical advance Published on: 1 October 2015

   • View Full Text
   • View PDF